Applied Therapeutics Inc. (NASDAQ:APLT)
Old Forum Content for APLT
Make a Forum Post Become a member to view recent forum posts. Already a member? Sign in here.
-
DAN: ...
$APLT
$SQ -- Still running.
$SEDG -- Nope
- StockMarketMentor: A Price Alert has been triggered for $APLT Applied Therapeutics Inc.. Click here to view associated video clip: http://stockmarketmentor.com/stockanalysis.html?ticker=APLT&clip=124354
- pebbles: $APLT - Opp to buy or caution?
-
DAN: ...
$APLT -- Stpo below $44.80. Alert $44.80
$TTD -- Closed this too soon.
$NET -- This is your exit.
$SHOP -- Use trailing stops on this.
$VIPS -- Still printing higher highs and lows. Alert $20.50
$QDEL -- Soaking up supply at $210. Watching for mo ... - issues: Two of the best IBD industry groups in the medical field are 1) Biotech - group 4 - which includes: $NVAX $ADAP $CAPR $AKBA $APLT & $GMAB. The best are $NVAX $ADAP $AKBA & $CAPR The other IBD group is Medical products, group 13; $VIVO $LVGO $CODX $QDEL & $BSGM. We sold QDEL & AKBA at the high. We still hold $APLT $GMAB & $LVGO.
- Herb: @issues $NVAX $ADAP $CAPR $AKBA $APLT $GMAB $VIVO $LVGO $CODX $QDEL $BSGM $ADPT whackage AH
- issues: Thanks for whom ever posted $VXRT. It's in IBD group 4 (biotech esp vaccines!) along with $AIM $NVAX $TBIO $APLT $APTO and $CLDX. Bought starter positions in $VXRT and $CLDX vaccines... Took profits in $NVAX.
- adelshams: @Dan and @Scottrades any thought on IPO stock $APLT?
- scottrades: @adelshams $APLT In good uptrend! Looks like it trades thin though so there's some risk there.
- DAN: @adelshams $APLT Stay long. I couldn't buy it right here, but if you're long, stay that way.
- adelshams: @scottrades $APLT Thanks!
- adelshams: @DAN $APLT I am long on the stock, it is my fav stock. Another Dexcom...
- issues: I just had to sell $ACMR. Nothing can go up forever. Nice profit. I bought $UCTT and $ASYS. Holding $ENTG and $TER over earnings tonight. ALso holding $ADAP $APLT $AVDL $APTO. Biotech has fallen to IBD industry group 2. Anybody know what's group 1?
- bknpdx: @issues $ACMR $UCTT $ASYS $ENTG $TER $ADAP $APLT $AVDL $APTO Hi @issues - Biotech is still ranked #1 of the IBD industry Groups. #2 is Auto Mfg.; #3 is Wholesale Electronics.
- issues: Sold some $CZZ and $CLSD. Took some profits on the rocket ride $APLT, but kept 1/2. Totally out of $ISEE. Do you see? I see. Bought $APLS and added to $DTIL, $ORCL and $NTCO (Avon). Could'nt resist $WBA on this major pull back. Of course I put in a stop.
- Herb: Biotech of the day: $APLT
- issues: Biotech has gone from IBD group 4 to group 3 and today it's group 2! It constantly changes stocks in this very aggressive group. They are different again today. I look at first the ones under "accumulation" then under "relative strength." So the symbols under accumulation are: $ACIU $AUPH $ISEE $ALLK $APLT $ARAV $ARDX $ARWR & $CORT. The percent increases for the past 10 days start with $AUPH up a mere 160%, then $ISEE at 50%, then $ALLK at 35% then $ARAV at 30% and $APLT at 25% and $AVDL at 25%. Although many of these are at a high, I bought a small number of shares anticipating a drop down where I can add to holdings. So today I bought the following: $ARVN $ISEE $AVDL $ARDX Yesterday I sold $FTSV too soon at $26 (now it's $35) and $ARQL for a great profit.
- spmeyers: @issues $CLSD $ARAV $APLT $AQST $MDXG $OXFD $MLSS these Rocket Ship stocks are very risky, gotta watch them like a hawk or you can lose a lot very fast
- issues: Looking to buy one or more of these biotechs (IBD group 3!) : $CLSD $ARAV $APLT $AQST $MDXG $OXFD $MLSS
- gwenzee: @issues $CLSD $ARAV $APLT $AQST $MDXG $OXFD $MLSS I'd start to pare this list down by eliminating all stocks under $10/share. Usually stocks are penny stocks for reason. Betting on them is a good way of losing your $$$.
- issues: @gwenzee $CLSD $ARAV $APLT $AQST $MDXG $OXFD $MLSS Thank you Gwen! I like your advice!
| Stock Price | $4.31 |
| Change | -3.36% |
| Volume | 770,114 |
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The lead product candidate of the company is AT-001, which is a novel ARI with broad systemic exposure and peripheral nerve permeability, developed for the treatment of diabetic cardiomyopathy, or DbCM, a fatal fibrosis of the heart.
Request Video of APLTAlready a member? Sign in here.
Past Month
Leading Peers
-
$6.35 284.27%
-
$12.29 280.99%
-
$7.42 262.04%
Past Month
Lagging Peers
-
$27.30 -79.24%
-
$6.58 -66.46%
-
$14.27 -57.62%
Dan Fitzpatrick
Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 30 day trial membership for just $7.77. Get started TODAY and start trading better TOMORROW with the following premium content:
- Nightly video Strategy Sessions with a game plan for tomorrow
- Got a stock you want Dan to look at? Just ask.
- Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
- Access to over 90,400 stock analysis videos
- Access an ever expanding library (90,400) of educational videos that will save you time and make you money
Join a team of friends and traders that have one thing in common; a burning desire to succeed.
Become a Member Today!
Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...
Satisfaction Guaranteed!
Your Stock Market Mentor membership comes with a 30 day, no questions asked, 100% money back guarantee!